首页> 外文会议>World congress on breast diseases >Protection of a cytidine deaminase gene gainst toxicity of high dose chemotherapy in mice
【24h】

Protection of a cytidine deaminase gene gainst toxicity of high dose chemotherapy in mice

机译:小鼠高剂量化疗的胞苷脱氨酶基因血淋力的保护

获取原文

摘要

@@Background and Aim:To explore the feasibility of transferring cytidine deaminase (CD) gene into mouse bone marrow cells in order to observe the drug resistance of high dose Ara-C and improve the tolerance of myelosuppression following combination chemotherapy. Methods:1 Separation of vectors and drug resistance genesThe retrovirus vectors containing drug resistance genes SFG-CD (containing human mutant Cytidine Deaminase, mCD) was transduced into amphotropic packaging cell (GP-Am12, Am12), and constructed AM12-SFG-CD. These vectors and cell lines were kindly provided by professor Shicheng Zhao (MSKCC).
机译:@@背景和宗旨:探讨将胞嘧啶脱氨酶(CD)基因转移到小鼠骨髓细胞中的可行性,以观察高剂量ARA-C的耐药性,提高组合化疗后骨髓抑制的耐受性。方法:将含有药物抗性基因SFG-CD(含有人突变体细胞苷脱氨酰酶,MCD)的载体分离和耐药性血管血管载体载体被转换成视铬封装细胞(GP-AM12,AM12),并构建AM12-SFG-CD。这些载体和细胞系是由赵教授(MSKCC)提供的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号